JUVE Eyes is a 1% polynucleotide (PN) skin booster developed specifically for the delicate periorbital zone, supplied as a single sterile 2 mL pre-filled syringe. Built on long-chain, highly purified polynucleotides derived from salmon DNA, JUVE Eyes works by priming dermal fibroblasts rather than by adding volume — stimulating the production of collagen, elastin and matrix glycosaminoglycans while holding water in the tissue. The result is brighter, denser, better-hydrated under-eye skin that looks rested rather than filled. For clinics building a regenerative eye-area offering, it is one of the most requested PN boosters on the Korean market.

What Is JUVE Eyes PN Skin Booster?

JUVE Eyes is an injectable polynucleotide skin booster at 1% concentration, formulated for the thin, mobile, easily-bruised skin around the eyes. It is delivered intradermally at 0.5–2 mm using very fine needles or a microneedling device, spreading a small dose across many points rather than depositing a bolus in one place.

The active ingredient is a natural-origin, highly purified long-chain polynucleotide — DNA fragments extracted from salmon, refined to remove protein and immunogenic material. Once in the dermis, these polynucleotides do two jobs simultaneously: they signal fibroblasts to increase their regenerative activity, and their highly hydrophilic three-dimensional structure binds water and supports the extracellular matrix from within.

What Are Polynucleotides?

Polynucleotides are chains of nucleotides — the same building blocks that make up DNA. In the skin they behave as signalling molecules, comparable in role to messenger RNA: they carry instructions to skin cells about repair and renewal.

As skin ages, this cellular communication weakens. Fibroblasts become less responsive, cell turnover slows, and the structural proteins that keep skin firm — collagen and elastin — degrade faster than they are replaced. Around the eyes, where the dermis is at its thinnest and the vascular network sits close to the surface, this shows up early as dark circles, crepey texture and fine lines.

Injected polynucleotides restore that signal. They stimulate fibroblast activity, support the synthesis of new collagen and elastin fibrils, promote matrix glycosaminoglycan production, and exert a documented anti-inflammatory effect on the treated tissue. This is why PN is described as a regenerative treatment rather than a corrective one: the improvement comes from the skin’s own tissue response, which is also why results build progressively over a course rather than appearing entirely on day one.

How JUVE Eyes Works on the Under-Eye Area

Fibroblast Priming and Collagen Synthesis

JUVE Eyes primes dermal fibroblasts, promoting the production of new matrix glycosaminoglycans, collagen and elastin fibrils. In the periorbital zone this translates into measurably denser skin — and denser skin is less translucent, which is the mechanism behind the reduction in shadowing and dark circles.

Deep, Sustained Hydration

The polynucleotide chain is highly hydrophilic. It draws and holds water in the extracellular matrix, plumping the tissue from within and improving elasticity and turgor. This addresses the dehydrated, crepey quality of the under-eye area that no topical eye cream reaches.

Three-Dimensional Structural Support

Unlike simpler injectable actives, the polynucleotide in JUVE Eyes forms a three-dimensional porous structure within the dermis. That scaffold gives it a longer residence time in the tissue and provides genuine structural support during the skin’s regenerative response.

Anti-Inflammatory and Barrier Effect

Polynucleotides exert an anti-inflammatory effect and support skin barrier function. In the periorbital area — often reactive, often compromised by rubbing, allergy or product irritation — that calming action is a meaningful part of the visible improvement.

Key Benefits of JUVE Eyes

• Reduces dark circles and under-eye shadowing by increasing dermal density and reducing translucency
• Softens fine lines in the infraorbital and periorbital zone
• Boosts hydration and elasticity for a plumper, less crepey texture
• Refines uneven skin texture across the eye area and upper cheek
• Stimulates collagen and elastin synthesis for progressive, natural improvement
• Strengthens skin barrier function and calms reactive periorbital skin
• Normalises sebum production and supports intracellular metabolism
• Refreshes tired-looking eyes without volume overload or puffiness
• Suitable for all skin types with a low-trauma injection technique

Indications for JUVE Eyes

JUVE Eyes Product Specifications

JUVE Eyes Treatment Protocol

Before the Procedure

1. Ensure the packaging is intact and undamaged.
2. Check the expiration date to confirm product safety.
3. Check the syringe markings to confirm the correct dose.
4. Carefully screw the needle or cannula onto the syringe and ensure a secure fit.
5. Hold the syringe firmly and remove the protective cap from the needle end.

Injection Technique

Apply topical anaesthetic cream and allow it to take effect. Assess and map the treatment area, noting the distribution of shadowing, texture change and fine lines. Using a 32–34G × 4 mm needle, a Dermapen or a Mesoscooter, deliver 0.005–0.01 mL per point at a depth of 0.5–2 mm and an angle of 35–45°, using a nappage or micropapular technique across the treatment field.

Because this is intradermal skin-quality work rather than volume placement, the objective is even coverage across the zone — not depth or bolus volume. Injectors experienced with HA tear trough filler should note that this is a different technique in a different plane, and should not transfer deep microbolus habits to a PN booster.

Course and Aftercare

Polynucleotide boosters build results cumulatively. Practitioners commonly run an initial course of several sessions spaced two to four weeks apart, followed by maintenance every few months, with the exact schedule set by the treating clinician based on the patient’s skin and response.

Advise patients to avoid touching, massaging or applying makeup to the treated area for 24 hours, and to avoid saunas, intense heat and strenuous exercise for the first day or two. Minor swelling, redness or bruising may occur and typically settles within a few days.

Safety, Precautions and Contraindications

Do Not Use In

• Patients with active infection or inflammation at or near the treatment site
• Patients with known hypersensitivity to any component of the product
• Patients with fish or salmon allergy — the polynucleotide is salmon-derived, and this must be established at consultation
• Patients with autoimmune disease or bleeding disorders without individual clinical assessment
• Pregnancy and breastfeeding

What to Expect

Minor swelling, redness, pinpoint bleeding or bruising at injection sites is common and generally resolves within a few days. The under-eye area bruises more readily than most of the face, and patients should be counselled accordingly and scheduled with social downtime in mind. A full assessment is required before treatment, and any persistent, severe or unexpected reaction should be reviewed by the treating practitioner immediately.

Storage and Handling

• Store at room temperature, 1°C to 25°C.
• Protect from direct sunlight — keep the syringe in its original carton.
• Do not freeze and do not expose to direct heat.
• Shelf life: 24 months from manufacture. Check the printed expiry date on the box before use.
• Sterile, single use only — never reuse or share a syringe between patients.
• Inspect before use — do not use if the packaging is damaged or the solution is discoloured or contains particles.

Buy JUVE Eyes PN Skin Booster Wholesale

Frequently Asked Questions About JUVE Eyes

What is JUVE Eyes made of?

JUVE Eyes contains 1% polynucleotide (PN) — natural-origin, highly purified, long-chain DNA fragments derived from salmon. It is supplied as a 2 mL sterile single-use pre-filled syringe with instructions for use.

Is JUVE Eyes a filler or a skin booster?

JUVE Eyes is a skin booster, not a dermal filler. It does not add volume to fill a hollow. It works by stimulating dermal fibroblasts to improve the skin’s own collagen, elastin and hydration — improving the quality, density and brightness of the under-eye skin rather than its shape. Patients whose main concern is true volume loss in the tear trough may need a hyaluronic acid filler instead of, or in addition to, a PN booster.

How does JUVE Eyes reduce dark circles?

Much under-eye darkness comes from thin, translucent skin allowing underlying vasculature and pigment to show through. By stimulating collagen and elastin synthesis and improving dermal hydration, JUVE Eyes increases the density and thickness of that skin, which reduces the shadowing effect. It also has an anti-inflammatory action that helps calm reactive periorbital skin.

How long does JUVE Eyes last?

The effect of JUVE Eyes lasts approximately 6 to 12 months, depending on the individual patient, their skin condition and the number of sessions completed. Because polynucleotides work by stimulating the skin’s own regenerative processes, results build progressively across a course rather than peaking immediately.

How is JUVE Eyes injected?

JUVE Eyes is injected intradermally at a depth of 0.5–2 mm using a 32–34G × 4 mm needle, Dermapen or Mesoscooter, at an angle of 35–45°, delivering 0.005–0.01 mL per point using a nappage or micropapular technique. Topical anaesthetic cream is applied beforehand.

How many sessions of JUVE Eyes are needed?

Polynucleotide boosters are cumulative, so practitioners commonly run an initial course of several sessions spaced two to four weeks apart, followed by periodic maintenance. The exact protocol is set by the treating clinician based on the patient’s skin condition and response.

What is the difference between PN and PDRN?

Both derive from purified salmon DNA. PDRN (polydeoxyribonucleotide) consists of shorter DNA fragments that act primarily through adenosine A2A receptor activation. PN (polynucleotide) uses longer chains that additionally form a three-dimensional hydrophilic scaffold in the dermis, giving greater structural support and water-binding capacity. JUVE Eyes uses long-chain PN at 1%.

Is JUVE Eyes safe for all skin types?

JUVE Eyes is formulated for use across all skin types. However, because the polynucleotide is salmon-derived, it must not be used in patients with a fish or salmon allergy, and it is contraindicated in active infection at the site and in known hypersensitivity to any component. A full assessment is required before every treatment.

Does JUVE Eyes cause swelling or puffiness?

JUVE Eyes is designed to refresh the eye area without the volume overload or heaviness that can follow over-filling. Minor swelling, redness or bruising at injection points is common in the first few days after treatment and typically settles quickly, though the under-eye area bruises more readily than most of the face.

How should JUVE Eyes be stored?

Store JUVE Eyes at room temperature between 1°C and 25°C, protected from direct sunlight. Do not freeze and do not expose to direct heat. Unopened product has a 24-month shelf life from date of manufacture.

Can JUVE Eyes be combined with other treatments?

Practitioners commonly combine polynucleotide boosters with other modalities across a treatment plan — for example hyaluronic acid filler where genuine volume loss is present, or botulinum toxin for dynamic crow’s feet. Sequencing and spacing are clinical decisions for the treating practitioner.

Can I buy JUVE Eyes wholesale?

Yes. Fillers Wholesale supplies JUVE Eyes PN 1% at wholesale prices to clinics, distributors and licensed aesthetic practitioners, with volume discounts on bulk orders and worldwide shipping. Contact our team for a quotation.

Related Skin Boosters and Eye Treatments

Browse our full range of wholesale skin boosters and PDRN injections for other regenerative options. Where true volume loss is the concern rather than skin quality, see our dermal fillers range. Add a topical numbing cream for comfortable periorbital sessions, and review our ODM / OEM services if you are developing your own polynucleotide line.